If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
New patient-friendly option to be made available for Tev-Tropin JERUSALEM & EWING, N.J.–(HSMN NewsFeed)–Teva Clinical Industries Ltd. (Nasdaq: TEVA ) and its partner, Antares Pharmaceutical, Inc. (NYSE Amex: AIS) today announced the approval of a Supple…
Biopharmaceuticals, Drug Delivery, FDA
Teva Pharmaceutical, Antares Pharma, Tev-Tropin
Posts from ‘June, 2009’
Teva and Antares Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin(R) (Human Growth Hormone)
Watson Pharmaceuticals Appoints Christopher W. Bodine to Board of Directors
Former President, Health Care Services for CVS Caremark Corporation Brings Added Global Supply Chain Experience and Expertise to the Board MORRISTOWN, N.J., June 29 (HSMN NewsFeed) — Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leader in generic and …
Biopharmaceuticals, Personnel
Watson Pharmaceuticals
DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation
PRINCETON, N.J., June 29 (HSMN NewsFeed) — DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB ), a late-stage biopharmaceutical company, announced today that investigators at the Fred Hutchinson Cancer Research Center, Seattle, Washingto…
Biopharmaceuticals
DOR BioPharma, orBec , beclomethasone, GI GVHD
Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Pharma Officer
Dr. Sherman also elected President of the Drug Information Association (DIA) NORTHBROOK, Ill., June 29 (HSMN NewsFeed) — Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today announced the appointment of Jeffrey W. Sherman, M….
Biopharmaceuticals, Personnel
Horizon Therapeutics
Wake Pharm US Announces Appointment of Jeffrey A. Niezgoda, M.D. to the Board of Medical Advisors
ELK GROVE VILLAGE, Ill., June 29 (HSMN NewsFeed) — Wake Pharm US announced today the appointment of Jeffrey A. Niezgoda, MD, FACHM, FACEP, FAPWCA as Director of the Company’s Clinical Advisory Board. Dr. Jeffrey Niezgoda is a leading wound management …
Biopharmaceuticals, Wound Care, Personnel
Wake Pharm US
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa. and KENILWORTH, N.J., June 26 (HSMN NewsFeed) — Centocor Ortho Biotech Inc. and Schering-Plough Corporation (N…
Biopharmaceuticasl, Regulatory
Schering-Plough, Centocor Ortho Biotech, SIMPONI, golimumab
AZZALURE(R) Approved in Germany for Aesthetic Use in the Treatment of Glabellar Lines
This market authorisation is part of a process including 15 countries in Europe Azzalure(R) will be commercialised in Germany by Galderma PARIS & LAUSANNE, Switzerland–(HSMN NewsFeed)–Galderma, the top pharma company in dermatology, and …
Biopharmaceuticals, Dermatology, Regulatory
Ipsen, Galderma, Azzalure, botulinum toxin Type A, glabellar lines
Dermatologic and Ophthalmic Drugs Advisory Committee Unanimously Recommends Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
IRVINE, Calif., June 26 (HSMN NewsFeed) — ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ) today announced the Dermatologic and Ophthalmic Drugs Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended the approval of Bepreve(TM…
Biopharmaceuticals, Ophthalmology
ISTA Pharmaceuticals, Bepreve, bepotastine
MedPro Imaging Adds Wayman and Sanford to Growing Sales Team
Robust Growth Prompts Addition of Veteran Revenue Executives to Premium Provider of New and Refurbished Ultrasound Solutions WAUKESHA, Wis., June 20 five (HSMN NewsFeed) — MedPro Imaging, a premium provider of new and refurbished ultrasound solutions, annou…
Devices, Distribution, Personnel
MedPro Imaging
Richard A. Meier Appointed to STAAR Surgical Board of Directors
Former President and COO of Advanced Laboratory Optics Brings Significant Industry Background to STAAR’s Board MONROVIA, Calif., June 25 (HSMN NewsFeed) — STAAR Surgical Company (Nasdaq: STAA ), a developer, manufacturer and marketer of implantable lens…
Devices, Ophthalmology, Personnel
STAAR Surgical
